Telocytes in Placental Tissues of Patients With Gestational and Pre-gestational Diabetes

NCT05305326 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2022-03-31

No results posted yet for this study

Summary

Examining the expression of telocytes in the placental tissues and umbilical cord of patients with gestational or pregestational diabetes during pregnancy compared to control.

Conditions

  • Diabetes in Pregnancy

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Principal Investigators

  • Amr O Abdelkareem, MD · Sohag Faculty of Medicine

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05305326 on ClinicalTrials.gov